HYBRID EVENT: You can participate in person at Rome, Italy or Virtually from your home or work.

3rd Edition of

International Ophthalmology Conference

March 10-12, 2025 | Rome, Italy

IOC 2025

Optimization of the ocular surface using Intense Pulsed Light (IPL) therapy before cataract surgery

Speaker at International Ophthalmology Conference 2025 - Dmytro Zhaboiedov
Bogomolets National Medical University, Ukraine
Title : Optimization of the ocular surface using Intense Pulsed Light (IPL) therapy before cataract surgery

Abstract:

Introduction: Dry eye disease (DED) is a prevalent condition among patients undergoing cataract surgery, significantly impacting preoperative measurements and postoperative recovery. One of the primary contributors to DED is meibomian gland dysfunction (MGD), which leads to tear film instability and inflammation of the ocular surface. Intense Pulsed Light (IPL) therapy has emerged as a promising treatment for MGD-related DED by improving meibomian gland function, reducing inflammation, and stabilizing the tear film.
Optimizing the ocular surface before cataract surgery is essential for accurate intraocular lens (IOL) calculations, corneal topography assessments, and improving overall surgical outcomes. IPL therapy offers a non-invasive and effective approach to enhance ocular surface health, ensuring better surgical precision and faster postoperative recovery.
Materials and methods: The study included 60 patients with an average age of 71±5.4 years, including 32 women and  28 men. All patients were diagnosed with dry eye disease before cataract surgery. Assessment was performed according to the following measures: Ocular Surface Disease Index (OSDI), tear break-up time (TBUT), ocular staining with fluorescein assessed with the Ocular Staining Score, and Schirmer test. Standard IPL treatment regimen consists of: 3 sessions spaced 2 to 4 weeks apart before cataract surgery and lubricating eye drops.
Results: Patients undergoing IPL therapy exhibit longer tear break-up time (TBUT) values, demonstrating enhanced tear film integrity. TBUT improvements correlate with reduced tear evaporation and greater ocular comfort in pre- and post-cataract surgery evaluations.IPL has been found to significantly lower matrix metalloproteinase-9 (MMP-9) levels, a biomarker associated with ocular surface inflammation in dry eye disease (DED). A decrease in inflammatory cytokines and telangiectatic blood vessels leads to less ocular redness, irritation, and discomfort.
Conclusion: Intense Pulsed Light (IPL) therapy is a highly effective and non-invasive method for optimizing the ocular surface before cataract surgery. By improving meibomian gland function, reducing inflammation, and stabilizing the tear film, IPL enhances preoperative assessments, surgical precision, and postoperative recovery. Integrating IPL therapy into the pre-surgical management of cataract patients with DED can lead to better surgical outcomes and improved patient satisfaction.

Biography:

Dr. Dmytro Zhaboiedov is a Professor of Ophthalmology and Chair of the Department of Ophthalmology at Bogomolets National Medical University. He earned his Ph.D. in Ophthalmology with a dissertation focused on intraocular lens implantation without capsular support and the development of new surgical techniques. Later, he defended his Doctor of Science (D.Sc.) thesis, which addressed issues of visual quality in patients with age-related cataracts through the study of surgical performance metrics. His clinical and research expertise spans advanced microsurgical techniques for cataract, glaucoma, retinal detachment, and ocular trauma. Dr. Zhaboiedov has introduced innovative methods for intraocular lens fixation and pioneered laser technologies for retinal disease treatment. He is an active member of international ophthalmological societies, has authored over 210 scientific publications, and holds multiple patents for ophthalmic surgical innovations

Watsapp